stella
beta
Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites — Stella
Recruiting
Back to Ovarian Neoplasms Malignant trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Trial locations
(1 site)
China
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov